U.S. Seeks Patent On Ebola Virus

International Business Times: The U.S. Government Wants To Patent The Ebola Virus, Here’s Why That’s A Good Thing
“U.S. government researchers are embroiled in a five-year fight with the Patent and Trademark office for a patent on the Ebola virus. Though the effort sounds ominous, it could accelerate the pace of research into an Ebola vaccine by preventing pharmaceutical companies from monopolizing the field…” (Caulderwood, 11/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.